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Background: Perivascular Spaces (PVS), visible on brain magnetic resonance imaging 
(MRI), are thought to be associated with small vessel disease (SVD), neuroinflammation, and 
to be important for cerebral haemodynamics and interstitial fluid drainage. 
 
Aims: To benchmark current knowledge on PVS associations with risk factors, neurological 
disorders, and neuroimaging lesions, using systematic review and meta-analysis. 
 
Summary of review: We searched three databases for PVS publications, calculated odds 
ratios with 95% confidence interval and performed meta-analyses to assess adjusted 
associations with PVS. We identified 116 relevant studies (n=36,108) but only 23 (n=12,725) 
were meta-analysable. PVS assessment, imaging and clinical definitions varied. PVS were 
associated (n; OR, 95%CI, p) with ageing (8395; 1.47, 1.28-1.69, p=0.00001), hypertension 
(7872; 1.67, 1.20-2.31, p=0.002), lacunes (4894; 3.56, 1.39-9.14, p=0.008), microbleeds 
(5015; 2.26, 1.04-4.90, p=0.04) but not WMH (4974; 1.54, 0.71-3.32, p=0.27), stroke or 
cognitive impairment. There was between-study heterogeneity. Lack of appropriate data on 
other brain disorders and demographic features such as ethnicity precluded analysis. 
 
Conclusions: Despite many studies, more are required to determine potential 
pathophysiological PVS involvement in cerebrovascular, neurodegenerative and 





Perivascular spaces (PVS), also known as Virchow-Robin Spaces, are seen on magnetic 
resonance imaging (MRI) as thin linear or small punctate structures, of similar signal to CSF, 
in deep grey or white matter.1 Increasing numbers of reports have detailed associations of 
visible PVS on MRI over the last two decades, notably with small vessel disease (SVD) 
lesions. PVS may provide an early biomarker for diagnosing developing disorders such as 
white matter hyperintensities (WMH)2 which increase the risk of stroke and dementia,3 or 
neurodegenerative diseases,4 and are highly heritable.5 
 
We aimed to benchmark current knowledge of associations between PVS and vascular risk 
factors, common neurological disorders and neuroimaging findings using systematic review 




We registered the study protocol (PROSPERO, CRD42017056052) and used the Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Guidelines6. 
  
Search Strategy 
We searched comprehensively for studies published in full up to January 14, 2017, in 
PubMed, Web of Science and Ovid EMBASE. The search keywords included “perivascular 
spaces”, “perivascular space”, “Virchow-robin spaces”, or “Virchow-robin space”, combined 
with “MRI”, “MR” or “magnetic resonance”. We assessed articles with any combination of 
the above keywords and checked reference lists of review papers, our files, and hand 
searched the last five years of Stroke. 
 
Inclusion and Exclusion Criteria 
We aimed to include all papers that reported on PVS associations with vascular risk factors, 
common neurological disorders particularly cognitive impairment, dementia or stroke, or 
neuroimaging signs of vascular disease.  We excluded case reports, animal studies and 
reviews without original data, studies with fewer than 10 subjects, on rare diseases, that were 
not published in English (we lacked resources for translation), lacked MRI, or did not provide 




Data Extraction  
We removed duplicates, screened the remaining titles and abstracts, removed irrelevant 
papers and assessed the remaining potentially eligible papers for inclusion.  
Two reviewers (FFF, LB) extracted title, authors, publication year, number of subjects, mean 
age, sex, PVS location (basal ganglia, centrum semiovale, midbrain or hippocampus), rating 
method and scale used, and results of associations, including whether adjusted for major 
covariates. We used results that had been adjusted for major covariates wherever they were 
available. 
 
We extracted criteria on study quality, four on risk of bias (patient selection, index test, 
reference standard, study timing) and three on applicability (patient selection, index test, 
reference standard), from the Quality Assessment of Diagnostic Accuracy Studies 2 
(QUADAS-2) criteria (https://www.ncbi.nlm.nih.gov/pubmed/22007046).   
 
We excluded duplicate data, including only the most recent or largest dataset from studies 
with multiple publications, but included all available outcomes. Disagreement was resolved 
by consensus or by a third reviewer (JW) who also double-checked the data extraction (JW).  
 
Where associations were not provided as odds ratios (ORs) and 95% Confidence Intervals 
(CI) we calculated the ORs and 95%CI if possible. Where relevant information appeared to 
be available but was not in the publication, we sought additional information from authors. 
Where studies met all inclusion criteria except for providing data for meta-analysable ORs, 
we performed a qualitative narrative summary of the findings.  
 
Statistical Analysis 
We entered the ORs and 95% CI into Review Manager Software Version 5.3 (Cochrane, 
Oxford) for meta-analysis. We used generic inverse variance method and random effects 
model, plotted multivariate adjusted ORs and 95%CI and generated summary ORs. We 
assessed between-study heterogeneity using  𝜒2 test, with p0.05 considered statistically 
significant, and used Higgin’s 𝐼2 test to calculate the percentage of variance across studies 
due to heterogeneity rather than chance.7 𝐼2 of 25% or less was considered low, 26%-50% or 
 5 
less moderate, 51-75% or less high and 76% and above as very high heterogeneity. We 





We identified 956 non-duplicate papers, and eliminated 301 studies based on title and 
abstract. Of the remaining 654 studies screened in full, 116 studies met the inclusion criteria. 
However, of these 116 studies, only 23/116 provided their results as ORs and were therefore 
suitable for meta-analysis. Supplementary Figure 1 summarises the search and selection.  
 
Characteristics of 23 studies included in meta-analysis 
The 23 studies with data suitable for meta-analysis included 12,725 patients (median N=268) 
from various demographic backgrounds (Table 1), performed in various geographical regions 
including the UK, Netherlands, Belgium, France, Sweden, China, Japan, USA and Canada.8-
14 The Northern Manhattan study included Hispanic, black,white and other populations,15 but 
no studies presented data by ethnic group. The cohorts included men and women of age >50.. 
They included individuals with previous history of stroke and patients from memory clinics. 
Several studies reported multiple association, e.g., ageing and hypertension vs. PVS.16  
 
On QUADAS-2 criteria, no studies were judged to have a high risk of bias, only 3/23 studies 
had unclear risk, with the rest being low risk; 3/23 studies were judged to have high risk of 
applicability concerns and the rest low risk (Supplementary Table 1). 
 
Most papers used 1.5T MRI, 11/23 used T2 and the rest a mix of T1 and T2 sequences to 
identify PVS. Most studies reported on PVS in the basal ganglia (BG) and centrum semiovale 
(CS) although several papers reported PVS in the hippocampus.12, 13  
 
Several PVS rating scales were used, one of the commonest being the scale of Potter17 which 
classifies PVS by count into four categories from 0 (no PVS) to 4 (>40 PVS). Other papers 
used a categorical scale of Heier18 which classifies PVS by their diameters into three 
categories: grade 1 (<2mm), grade 2 (2-3 mm) and grade 3 (>3mm). Others include the scale 
of Patankar,19 which rates PVS according to brain regions, and the scale of Adams20 which 
rates PVS ≥1mm separately from ≥3mm. Several studies used their own PVS method.10, 21  
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The included studies distinguished PVS from lacunes, according to size, shape and location 
as described in the STRIVE standards.22  
 
Characteristics of 93 studies that could not be meta-analysed 
The 93/116 non-meta-analysable studies (n=23,383) assessed 52 different risk factors, 
clinical or neuroimaging variables for their associations with PVS (Supplementary Table 2) 
as follows (numbers are number of studies):   
Risk factors: ageing (4), hypertension (2), inflammation (2), hypercholesterolaemia (1) and 1 
study each on adiponectin, blood brain barrier, peptide levels, PTEN mutation, and retinal 
microvascular calibre; 
Clinical disorders: vascular disease unspecified (6), cognitive decline or Alzheimer’s disease 
(6), unspecified dementia (4), stroke (4), large artery atheroma (2), Parkinsons disease (2), 
HIV (3), multiple sclerosis (4), depression (3), headache (3), head injury (2), myotonic 
dystrophy (2), systemic lupus erythematosus (SLE)/immunocompromised patients (2), autism 
(3), obsessive compulsive disorder (2), glaucoma (2), and 1 study each on tuberous sclerosis, 
unspecified neurological disorders, CADASIL, Tourette syndrome, adrenoleukodystrophy, 
asthma, hydrocephalus, infection, AGU, sickle cell anaemia, normal pressure hydrocephalus;  
Neuroimaging: WMH (8), cerebral amyloid angiopathy (CAA) (5), microbleeds (1), 
microinfarcts (1), lacunes (1), and atrophy (1).  
 
Meta-Analysis 
The following meta-analyses of PVS associations are summarised in Table 2. There was no 




Ageing. Thirteen studies (n=8395) reported on ageing and PVS in BG, CS or Hippocampus 
(Table 2, Figure 1). PVS increased with age in all areas, most in the BG (OR 1.47, 95%CI 
1.28, 1.69, P<0.00001), then CS (OR=1.26, 95% Cl, 1.07-1.49, P=0.005), then hippocampus 
(OR-1.14, 95% Cl, 1.01, 1.30, P=0.03), difference between the three areas 𝜒2 = 7.10, P=0.03 
and between-study heterogeneity (BG, 𝜒2=218.80, p=0.00001, 𝐼2=96%; CS 𝜒2= 42.82, 
p=0.0001, 𝐼2=86%).  
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Figure 1 Forest plot of associations of PVS in BG, CS and Hippocampus with ageing 
 
Diabetes. Five studies (n=3095) found no association between diabetes and PVS (Table 2, 
Supplementary figure 2). 
 
Hypertension. Thirteen studies (n=7872) found BG PVS were associated with hypertension 
(OR=1.67, 95% Cl, 1.20-2.31, P=0.002), with significant between-study heterogeneity (𝜒2= 
63.72, p=0.00001, 𝐼2=84%), Figure 2. The direction of effect was similar for CS PVS but did 
not reach significance.   
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Figure 2 Forest plot of associations of PVS in BS and CS with hypertension 
 
Neurological Diseases 
Lacunar versus non-lacunar stroke. Five studies (n=1,173) showed no consistent association 
between BG or CS PVS in clinically-evident lacunar versus non-lacunar stroke subtypes,9, 13, 
21, 23, 24 (Table 2, Supplementary figure 3). However, stroke subtyping and imaging methods 
differed between studies.  
 
Acute stroke. Two studies (n=682)25, 26 found no association between acute stroke of any 
subtype and PVS, but only in CS (OR=3.99, 95% Cl, 0.47-34.17, P=0.21), (Table 2, 
Supplementary Figure 4).  
 
Cognitive impairment. Three studies (n=1,272) did not find an association between cognitive 
impairment and PVS in BG region (OR=1.21, 95% Cl, 0.84-1.73, P=0.31), Table 2, 
Supplementary Figure 5). Only 1 study27 assessed cognition and CS PVS finding a borderline 
significant association (OR=1.06, 95% Cl, 1.00-1.11). Amongst the 93 non-meta-analysable 
studies, only four assessed associations of PVS with dementia but all reported different 
statistics. Of these, three found that PVS were increased significantly in patients with 
dementia vs controls.19, 28, 29 Three other studies examined associations of PVS and cognitive 
impairment, of which two found increased PVS with declining cognition.30, 31  
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Neuroimaging Features:  
White matter hyperintensities. Eight studies (n=4974) examined WMH and PVS in BG and 
CS regions (Figure 3a). Although the direction of effect was for an association with WMH, it 
did not reach significance (OR 1.54, 95%CI 0.71, 3.32, P=0.27). Amongst the 93 non-meta-
analysable studies, eight (n=3,333, range 32-1818) reported on associations of PVS and 
WMH. These used different statistics (adjusted beta, r, rho, chi squared) precluding direct 
comparison. However, most found positive associations between BG PVS and WMH with 
adjusted betas of 0.19 (p<0.001)16 to 0.47 (p<0.0001),2 and only one found a negative 
association.32 
 
Lacunes. Four studies (n=4894) found an association between lacunes and PVS in the BG 
(OR= 3.56, 95% Cl, 1.39-9.14) but not CS region. There was high between-study 
heterogeneity (BG, 𝜒2=27.72, p=0.00001, 𝐼2=89%), Figure 3b. 
 
Microbleeds. Five studies (n=5015) found that cerebral microbleeds were associated with BG 
PVS (OR=2.26, 95% Cl, 1.25-4.00, P=0.04), but with between-study heterogeneity (𝜒2= 
27.35, p=0.00001, 𝐼2=85%), Figure 3c. There were insufficient data to compare PVS and 
microbleeds by lobar or deep location. 
 
Cortical Superficial Sclerosis (cSS). Two studies (n=1642) reporting on cSS and PVS found 
no association between combined BG and CS PVS and cSS (OR=2.28, 95% Cl, 0.75-9.13, 





Figure 3 Forest plot of associations of PVS in BG and CS with WMH (a), lacunes (b), and cerebral microbleeds (c) 
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Discussion 
We investigated vascular risk factor, clinical, and imaging lesion associates of PVS by meta-
analysing risk factor-adjusted odds ratios. Although we found 116 potentially relevant papers, 
only 23 studies provided meta-analysable data, representing nearly 13,000 participants from 
various demographic groups, world regions and ethnicities. Surprisingly, we did not find 
conclusive evidence that PVS were associated with some expected clinical or neuroimaging 
features, although we did find most expected risk factor associations. There was no consistent 
association of PVS with lacunar vs non-lacunar stroke and a surprising lack of meta-
analysable data on PVS and cognitive decline or dementia. Most surprisingly, although the 
direction of effect was positive, the association between PVS and WMH was not significant 
in meta-analysis.  
 
We used risk-factor adjusted ORs, suggesting that some previously described PVS-WMH 
associations may reflect shared co-associations or differences in population characteristics. 
However, most of the eight non-meta-analysable papers on WMH (Supplementary Table 2) 
did account for key co-variates and did show WMH to be associated with PVS. Thus, the 
overall direction of effect suggests that PVS are associated with WMH. For microbleeds, 
there were fewer studies but a larger sample size (Table 2) than WMH for meta-analysis, 
perhaps reflecting the more recent description of microbleeds with more consistent methods 
thus facilitating meta-analysis. Although we confirmed a PVS association with microbleeds, 
the high heterogeneity indicates that more data are required.  
 
Data were very limited for testing associations of PVS with stroke, cognitive impairment, 
dementia or sleep disorders. This was disappointing, since brain fluid drainage via PVS is 
thought to be important for maintaining brain health, and indicates the need for more 
research.  
 
We meta-analysed the BG and CS PVS separately, since regional PVS associations may 
differ, there are known vessel wall anatomical differences between the BG and CS, hence 
meta-analysing the regions separately was biologically plausible.19 Some variation in PVS 
associations between BG and CS may reflect a lack of data for one region indicating that 
+future studies should assess both regions. Alternatively, PVS may vary between brain 
regions, although the association of PVS and ageing, for which we had the most data, did not 
differ by brain region (Figure 2).  
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Overall, the studies had low risk of bias or applicability concerns (Supplementary Table 1), 
but there was high between-study heterogeneity for many associations, indicating the need 
for more data. Inconsistencies between studies included use of different PVS and lesion 
rating methods, disease diagnosis, scanner strength and sequences, although lack of data 
precluded further sensitivity testing. Alternatively, PVS differences may reflect unquantified 
demographic, genetic or environmental differences. The epidemiological origin of the cohorts 
may also influence results, however it was not possible to test effects of country or ethnic 
origin since the data were not provided. Although we did not find objective evidence of 
publication bias, it is likely to be present.33 We were not able to include non-English 
language publications, but found many papers and the meta-analysed studies included nearly 
13,000 subjects.   
 
Computational methods to assess PVS are now emerging,34-36 show promise for future large 
studies, may help reduce variability, and can provide PVS volume, orientation, location in the 
brain in addition to count or frequency which may increase sensitivity for detecting subtle 
associations.  Future research should maximise sample size, report imaging methods in detail, 
adjust analyses to account for important co-variates especially vascular risk factors and age, 
and assess a much wider range of subject groups to investigate more fully the characteristics 
of PVS in different clinical situations.  
 
Conclusion 
Ageing, hypertension, cerebral microbleeds and lacunes were associated with PVS in risk-
factor adjusted meta-analysis, with most data available for BG PVS. More studies are 
required to further validate the use of PVS as a risk marker for these diseases and to 
understand pathophysiological pathways for stroke, dementia and other common neurological 
disorders. Future studies should use consistent methods to determine PVS appearances, 
standard definitions and reporting of parameters for rating PVS.   
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Table 1: Characteristics of studies included in the meta-analysis. WMH: white matter hyperintensities, MB: microbleeds, CMB: cerebral 
microbleeds, ICH: intracranial haemorrhage. 







Disorder Associated Association test 
result,  







Type of scanner  
  
MRI sequence 













































































5 point NA,  
T1, T2 and 
FLAIR 








4 points NA  
T2 
























4 points 1.5T,  




































































4 points 1.5T,  
T2&FLAIR 
 












































UK 4 points NA  
T2 
 19 





Stroke-free Hypertension 1.14 (1.03-1.26) Overall US NA 1.5T,  
T1& FLAIR 
 





































































UK 4 points NA  
T2 




First ever lacunar 
stroke 
Hypertension 1.32 (1.05–1.65) BG Nether-
lands 
3 points 1.5T or 3T  
T2 
9 Loos et al 201542 118 
63 
First ever lacunar 
stroke 



















Higher lobar MB 
 
 
















US 4 points 3T,  
T1 and T2 
























Canada 3 points NA,  
T2 
12 Potter et al 201513 298 
68 





































































UK 4 points 1.5T,  
T1, T2 and 
FLAIR 
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Spain 4 points 1.5T,  
T1&T2 
 




Patients with first 
lacunar stroke 
Silet ischemic lesion 10.58 (3.40–32.92) BG Nether-
lands 
3 points 1.5T  
T2 

















Sweden 4 points 1.5T,  
T1, T2&FLAIR 
 












3 points 1.5T,  
T2 and FLAIR 





ICH  spontaneous 
supratentorial ICH 
 







































































Japan 4 points 1.5T  
T2 
19 Yang et al 201633 16 
NA 
Stroke Lacunar infarct 1.204 (0.872-1.662) 
 
BG China 3 points 1.5,  
T1 and 3T, T2 
20 Yao et al 201412 344 
 
50.8 
Mutation in the 












4 points 1.5T,  
T1, T2 and 
FLAIR 
21 Zhang et al 201421 1090 
NA 
































































China 4 points 3T,  





































France 4 points 1.5T,  


























1 Indicates total sample for the association of interest.  





OR 95% CI P I² 
Risk factors        








1.14 1.01-1.30 0.03 0% 




1.42 0.92-2.20 0.12 77% 




0.95 0.78-1.15 0.58 0% 
Neurological disorder        
Acute Stroke CS 2 682 3.99 0.47-34.17 0.21 93% 




0.92 0.54-1.55 0.75 36% 
Cognitive impairment BG 3 1272 1.21 0.84-1.73 0.31 51% 
Neuroimaging feature        




1.07 0.90-1.27 0.21 0% 




0.87 0.67-1.13 0.31 0% 




1.15 0.62-2.12 0.66 0% 
Cortical superficial siderosis BG/CS combined 2 1642 2.28 0.57-9.13 0.24 75% 
